Search

Your search keyword '"Schlenke, Peter"' showing total 8 results
Start Over Author "Schlenke, Peter" Language undetermined
8 results on '"Schlenke, Peter"'

1. Additional file 2 of Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study

Author

Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, and Schilcher, Gernot

Abstract

Additional file 2. Supplementary Materials and Methods.

Published
2021
Full Text
View/download PDF

2. Additional file 1 of Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study

Author

Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, and Schilcher, Gernot

Subjects
digestive system diseases
Abstract

Additional file 1: Table S1. Tabulation of immunocompromised patients. R-CHOP21—combination chemotherapy consisting of rituximab, cyclophosphamide, vincristine, prednisolone given in 21-day cycles; FOLFOX combination chemotherapy consisting of folic acid, 5-fluorouracil and oxaliplatin; DA 7 + 3—combination chemotherapy consisting of cytarabine given continuously for 7 days and daunorubicin given on 3 consecutive days.

Published
2021
Full Text
View/download PDF

3. Additional file 3 of Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study

Author

Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, and Schilcher, Gernot

Abstract

Additional file 3: Figure S1. Overall survival of the whole cohort (n = 120). Median follow-up of the whole cohort was 1.9 months (with follow-up truncated at 3 months), we totally observed 52 deaths which corresponds to 1-, 2-, and 3-month OS estimates of 60% (95% CI 51–68), 54% (45–63), and 54% (45–63). CI: confidential interval.

Published
2021
Full Text
View/download PDF

4. Additional file 6 of Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study

Author

Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, and Schilcher, Gernot

Abstract

Additional file 6: Figure S3. Standardized mean difference (SMD) plot. Blue squares denote Standardized mean differences (SMDs) in before weighting the inverse of the probability of treatment weight (IPTW). Yellow diamonds denote the SMDs after weighting the IPTW.

Published
2021
Full Text
View/download PDF

5. Additional file 6 of Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study

Author

Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, and Schilcher, Gernot

Abstract

Additional file 6: Figure S3. Standardized mean difference (SMD) plot. Blue squares denote Standardized mean differences (SMDs) in before weighting the inverse of the probability of treatment weight (IPTW). Yellow diamonds denote the SMDs after weighting the IPTW.

Published
2021
Full Text
View/download PDF

6. Additional file 5 of Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study

Author

Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, and Schilcher, Gernot

Abstract

Additional file 5: Figure S2. Histograms of the Propensity Score and the IPTW. (A) The propensity score can range from 0 to 1. Multiply by 100 to obtain probabilities (in percent) of having received CVP. (B) The IPTW was defined as the inverse of the probability of receiving the treatment that the patient received (i.e., the so-called “average treatment effect on the treated

Published
2021
Full Text
View/download PDF

7. Additional file 4 of Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study

Author

Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, and Schilcher, Gernot

Abstract

Additional file 4: Table S2. Univariable predictors of survival in the cohort (n = 120). BMI: body mass index; first wave: depicts patients treated during the first wave of COVID-19 in Austria between March 2020 and August 2020; mSOFA: modified sequential organ failure assessment, maxPEEP: depicts the maximum applied PEEP to achieve optimal ventilation; IL-6: interleukin 6; CRP-C-reactive protein; hs-TNT: high sensitive troponin T

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results